Albenza is a broad-spectrum antiparasitic medicine used to treat tapeworm, roundworm, and other helminth infections affecting the intestines, tissues, and organs. By blocking the parasites’ ability to absorb glucose, it starves them and halts reproduction, allowing the body to clear infection. Clinicians prescribe Albenza for conditions such as neurocysticercosis, hydatid disease, ascariasis, hookworm, whipworm, and pinworm. The medicine is typically taken with food; dosing and duration vary by diagnosis and age. Monitoring of liver enzymes and blood counts is recommended with longer courses. Always use under medical guidance to optimize safety, effectiveness, and prevention of reinfection in households too.
Albenza is a benzimidazole antiparasitic used to treat a broad range of helminth infections. It works by inhibiting microtubule formation in parasites, disrupting glucose uptake, and causing energy depletion and death. Clinically, it’s used for intestinal nematodes (ascariasis, hookworm, whipworm, pinworm), some cestode infections (taeniasis), and select tissue infections, notably neurocysticercosis (pork tapeworm larvae in the brain) and hydatid disease (Echinococcus). It is also used off-label for strongyloidiasis in some settings when preferred agents are not available.
Because albendazole’s absorption improves with fat, it is typically taken with food—especially for tissue infections where systemic levels matter. Treatment choice, dosing, and duration depend on the parasite species, burden of infection, and patient factors (age, liver function, pregnancy status). Household contacts may also need assessment to prevent reinfection, particularly with pinworm.
Always follow your clinician’s instructions and the specific product label you receive. Typical adult dosing examples include:
• Ascariasis, hookworm, whipworm: 400 mg orally as a single dose; in some cases, 400 mg once daily for 3 days. For whipworm, some clinicians prefer the 3‑day course to improve cure rates. Repeat stool testing may be needed to confirm clearance.
• Pinworm (enterobiasis): 400 mg as a single dose; repeat in 2 weeks to treat newly hatched worms. All household members and close contacts may need treatment and hygiene measures to prevent recurrence.
• Strongyloidiasis (alternative regimen when preferred therapy is not feasible): 400 mg once daily for 3–7 days, directed by a clinician. Follow-up testing is important due to risk of persistent infection.
• Taeniasis (tapeworm, non-invasive): 400 mg once daily for 3 days. A purge or laxative is not routinely required but may be considered in specific cases; clinical follow-up is recommended.
• Neurocysticercosis: 400 mg twice daily for 8–30 days; corticosteroids and anti-seizure drugs are often co-prescribed to manage inflammation and seizure risk. Ophthalmologic evaluation is recommended if ocular cysticercosis is suspected.
• Hydatid disease (Echinococcus): 400 mg twice daily in 28‑day cycles, with 14‑day breaks between cycles, typically for 3 cycles. Surgery or percutaneous procedures may be combined with drug therapy depending on cyst location and size.
Pediatric dosing is weight-based (commonly 15 mg/kg/day up to a maximum of 800 mg/day, divided twice daily for tissue infections). Tablets are often 200 mg and may be chewed or crushed to aid administration; confirm with the dispensing pharmacist. For tissue infections, take with a fatty meal to improve absorption. For some intestinal infections, your clinician may advise administration on an empty stomach to concentrate drug in the gut lumen—follow individualized guidance.
• Liver health: Albendazole is hepatically metabolized. Baseline and periodic liver function tests (ALT/AST) are recommended, especially when therapy exceeds 14 days or is repeated in cycles. Stop and seek care if you develop jaundice, dark urine, severe fatigue, or right upper quadrant pain.
• Bone marrow suppression: Rare cases of leukopenia and pancytopenia have been reported, particularly with prolonged courses. A complete blood count should be monitored during extended therapy or in patients with preexisting hematologic issues.
• Neurologic monitoring in neurocysticercosis: As cysts die, inflammation can transiently worsen symptoms (headaches, seizures, focal deficits). Corticosteroids and anticonvulsants are frequently used; close medical supervision is essential.
• Pregnancy and contraception: Albendazole is teratogenic in animals. Avoid use in pregnancy unless potential benefits outweigh risks. Women of reproductive potential should have a pregnancy test before starting prolonged therapy and use effective contraception during treatment and for at least 1 month after the last dose.
• Breastfeeding: Data suggest low levels in breast milk; discuss risks and benefits with a clinician, especially for prolonged or repeated courses.
• Ocular disease: Rule out retinal cysticercosis before treating systemic cysticercosis because therapy may provoke ocular inflammation that could threaten vision.
• Known hypersensitivity to albendazole or other benzimidazoles (e.g., mebendazole).
• Pregnancy: Avoid unless no suitable alternatives exist and the potential benefit justifies the potential risk; consult a specialist.
• Severe hepatic impairment: Use with caution and specialist oversight; alternative therapies may be preferred.
• Preexisting significant bone marrow suppression: Requires individualized risk-benefit assessment and close monitoring.
Most patients tolerate short courses well. Common reactions include headache, abdominal pain, nausea, vomiting, diarrhea, dizziness, and reversible hair thinning. Transient elevations in liver enzymes can occur and are usually asymptomatic. With longer or high-intensity regimens, less common but more serious effects may include:
• Hepatotoxicity: Persistent transaminase elevations, hepatitis, or (rarely) severe liver injury. Monitoring helps detect early changes.
• Hematologic effects: Leukopenia, neutropenia, pancytopenia—especially with prolonged therapy or in patients with compromised marrow function.
• Hypersensitivity: Rash, urticaria, pruritus, or angioedema; discontinue and seek care if significant allergic symptoms develop.
• Neurologic events in neurocysticercosis: Worsening seizures, increased intracranial pressure, or focal deficits due to inflammatory responses as parasites die; co-management with steroids/anticonvulsants is standard.
• Very rare events: Aplastic anemia, severe cutaneous reactions, and renal injury have been reported. Report unusual bruising, infections, persistent fever, severe fatigue, or mucosal ulcerations immediately.
Albendazole is extensively metabolized in the liver to its active sulfoxide metabolite. Concentrations can be affected by co-medications:
• Increase albendazole levels: Dexamethasone, cimetidine, and praziquantel may raise active metabolite levels. Your clinician may adjust dosing or monitor labs accordingly, especially in prolonged treatments.
• Decrease albendazole levels: Enzyme inducers such as carbamazepine, phenytoin, phenobarbital, and rifampin can reduce effectiveness by lowering drug exposure. Alternative antiparasitics or dosage strategies may be considered.
• Hepatotoxic combinations: Caution when used with other hepatotoxic drugs (e.g., high-dose acetaminophen, certain antifungals, or methotrexate). Baseline and periodic LFTs are prudent when combinations are unavoidable.
• Food and grapefruit: A fatty meal increases absorption and is recommended for tissue infections. Grapefruit may alter metabolism of various drugs; discuss its use with your pharmacist.
If you miss a dose, take it when you remember unless it’s close to the next dose. If it is, skip the missed dose and resume your regular schedule. Do not double doses. For single-dose regimens (e.g., pinworm), contact your clinician if you miss the scheduled dose to plan an appropriate catch-up time.
There is limited experience with albendazole overdose. Expected symptoms may include intensified gastrointestinal upset, headache, dizziness, or laboratory abnormalities (elevated liver enzymes, cytopenias) with substantial or prolonged excess. There is no specific antidote; treatment is supportive.
If an overdose is suspected, contact your clinician, local emergency services, or Poison Control (in the U.S., 1-800-222-1222) immediately. Bring the medication container for reference. Monitoring may include vital signs, CBC, and liver enzymes.
Store Albenza tablets at controlled room temperature (generally 20–25°C/68–77°F), protected from excessive heat, humidity, and light. Keep in the original child-resistant container with the label intact. Do not use past the expiration date. Keep out of reach of children and pets, and dispose of unused tablets according to pharmacist guidance or community take-back programs.
In the United States, albendazole (Albenza) is a prescription medication. While some people search “buy Albenza without prescription,” legitimate, patient‑first pathways require medical oversight to ensure the right diagnosis, dosing, monitoring, and safety labs when indicated. This protects patients from inappropriate use, drug interactions, and avoidable side effects.
HealthSouth Hospital of Altamonte Springs operates within U.S. laws and professional standards. If you do not have an existing prescription, the pharmacy can connect you with licensed clinicians for a lawful evaluation—often via telehealth—so that, when appropriate, a valid prescription is issued and dispensed. This streamlined, structured approach means you do not need to bring a paper prescription in hand, yet your care still includes proper diagnosis, counseling, and monitoring requirements.
What to expect with a compliant process: symptom review and exposure history, consideration of stool or serologic testing when indicated, discussion of treatment options (including non‑pharmacologic measures), review of medical history and medications for interactions, and a plan for follow‑up (e.g., repeat dosing for pinworm, lab monitoring for prolonged therapy). You also receive counseling on hygiene, reinfection prevention, and when to seek urgent care.
Talk with a HealthSouth Hospital of Altamonte Springs pharmacist about availability of Albenza tablets 200 mg, generic albendazole options, pricing, and shipping. The team prioritizes transparency, privacy, and evidence‑based care—so access remains convenient without compromising the legal and clinical safeguards that keep treatment safe and effective.
Albenza is an antiparasitic that binds parasite beta-tubulin, disrupting microtubules, depleting energy (ATP), and killing susceptible worms and larvae.
It is approved for hydatid disease and neurocysticercosis and widely used for pinworm, roundworm (Ascaris), hookworm, whipworm, strongyloidiasis, cutaneous larva migrans, and toxocariasis, per local guidelines.
Take with food—preferably a fatty meal—to improve absorption, unless your clinician instructs otherwise for intestinal-only infections.
Usually mild: stomach upset, nausea, headache, dizziness, temporary hair thinning. Serious but uncommon: liver enzyme elevation, rash, bone marrow suppression.
For short single-dose regimens, typically no. For prolonged or high-dose courses, periodic liver tests and complete blood counts are recommended.
Avoid if allergic to albendazole or other benzimidazoles, in the first trimester of pregnancy, and use caution with active liver disease or bone marrow issues.
Avoid in the first trimester. If benefits outweigh risks later in pregnancy, it may be considered by a specialist. Small amounts enter breast milk; single-dose therapy is generally considered compatible—discuss timing with your clinician.
Dexamethasone, cimetidine, and praziquantel can raise albendazole levels; enzyme inducers like phenytoin, carbamazepine, and phenobarbital can lower them. Always review your medication list.
Dosing depends on the parasite and your weight. Many intestinal worms are treated with a single 400 mg dose (often repeated in 2 weeks), while tissue infections require longer, supervised regimens.
Often yes for pinworm and some intestinal worms—commonly a second dose at 2 weeks to catch newly hatched parasites, plus household hygiene measures.
Yes. It’s widely used in children, with doses based on age and weight. Age cutoffs and indications vary by country, so follow pediatric guidance.
Its active metabolite has a half-life of about 8–12 hours, so most of the drug clears within a couple of days after the last dose.
Yes for certain species and larval infections (like neurocysticercosis); for adult tapeworms in the intestine, praziquantel is often preferred depending on species.
There’s no specific alcohol reaction, but alcohol can strain the liver. If you’re on a prolonged course, it’s best to minimize or avoid alcohol.
Store at room temperature, dry, and away from light. If you miss a dose on a multi-day regimen, take it when remembered unless it’s close to the next dose—don’t double up.
Often yes—treating household contacts and strict hygiene (handwashing, nail trimming, laundering bedding) help prevent reinfection.
In neurocysticercosis, killing cysts can trigger inflammation causing headaches, seizures, or vision changes; doctors often co-prescribe steroids and anti-seizure meds.
Yes. FDA- or authority-approved generics contain the same active ingredient and are considered therapeutic equivalents.
It begins acting after absorption with peak levels within hours; symptom relief and stool clearance timelines vary by parasite and site of infection.
Clinically significant resistance is uncommon but reported in some settings; adherence to correct dosing and public health measures helps preserve effectiveness.
Both are benzimidazoles and work well; albendazole is often favored for broader tissue penetration and single-dose convenience, while mebendazole is excellent for intestinal-only infections.
Both are avoided in the first trimester. If treatment is needed later, many guidelines slightly prefer mebendazole due to more historical data, but decisions are individualized.
Both are well tolerated short term. Albendazole has more monitoring needs in long courses (liver enzymes, blood counts), while mebendazole may cause more GI upset in some users.
Ivermectin is first-line for strongyloidiasis; albendazole is an alternative when ivermectin can’t be used or as combination therapy in select cases.
Ivermectin (topical or oral) is used for scabies and difficult lice; albendazole is not a standard therapy for these ectoparasites.
Praziquantel is preferred for most adult tapeworms and all schistosome/fluke infections; albendazole is crucial for larval tapeworm disease (neurocysticercosis) and echinococcosis.
Pyrantel is an OTC option and works well; albendazole is prescription and also effective. Choice depends on availability, cost, and clinician preference.
Nitazoxanide (or metronidazole/tinidazole) is used for Giardia; albendazole can be an alternative in some settings but is not usually first-line.
Albendazole is generally better tolerated; thiabendazole is effective but has higher rates of side effects and is seldom used now.
Both are benzimidazoles, but flubendazole is not widely approved for humans in many countries; albendazole has broader human indications and availability.
No. Fenbendazole products for animals aren’t approved or quality-controlled for humans. Use human-approved albendazole under medical guidance.
DEC is used for many filarial infections; albendazole is often combined with DEC or ivermectin in mass drug administration programs to enhance efficacy.
Albendazole achieves higher systemic levels and is preferred when parasites invade tissues (e.g., cysticercosis, echinococcosis); mebendazole mainly acts in the gut.
Praziquantel and albendazole both interact with CYP-modifying drugs; albendazole’s levels are especially affected by cimetidine, dexamethasone, and enzyme-inducing antiepileptics.